Medication info
Tastin Tablets 4 mg (Pitavastatin Calcium Hydrate)

Tastin Tablets 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
Wonders Pharmaceutical Co., Ltd.
Appearance
Light yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202103491 · Approved 2021.04.29 · Insurance code 660703620

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medication is maintained with continued treatment.

Ingredients

Manufacturer
Wonders Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo-B protein
  • elevated triglyceride levels
View approved original text

This medication helps to control blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is used particularly to lower total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing HDL cholesterol levels to improve vascular health. This effect is enhanced when combined with a proper diet. Ultimately, this drug contributes to reducing the risk of cardiovascular diseases through the improvement of blood lipid profiles.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medication is maintained with continued treatment.

Precautions

This medication should not be used in certain patients. For example, patients with allergies to any components of this medication, patients with active liver disease, severe liver dysfunction or biliary obstruction, and those taking cyclosporine should not use it. Additionally, it should not be used in patients with myopathy, during pregnancy or in those who may become pregnant, nursing mothers, and children. Those with lactose intolerance or allergies to soybean oil, soy, or peanuts should also avoid taking this medication. Patients with impaired kidney or liver function, those consuming alcohol in excess, elderly individuals, or those with hypothyroidism should use this medication with caution. Particularly, when taken with fibrates or nicotinic acid, there is a heightened risk of muscle damage and deterioration of kidney function, so co-administration should be avoided or done with extreme caution. During the course of this treatment, atypical symptoms such as muscle pain, weakness, abdominal pain, rash, or itching may occur, and there can be deterioration of liver function or blood abnormalities. Rarely, a serious side effect associated with muscle damage known as rhabdomyolysis may occur, so if symptoms such as muscle pain or weakness arise, it is essential to inform medical personnel immediately. Before and during treatment, regular liver function tests should be conducted to monitor liver health, and blood lipid levels should be monitored to assess therapeutic efficacy. This medication should be used alongside dietary and exercise therapies, and cardiovascular risk factors such as hypertension or smoking should also be managed. Pregnant or nursing women should avoid this medication due to potential risks to the fetus or newborn, and women planning to become pregnant should consult with medical personnel before use. This medication should be swallowed whole without dividing, and kept out of reach of children. Also, it should be stored in its original container to maintain its quality and safety.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 78 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness of the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • feeling weak
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • dysgeusia
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial swelling
  • limb swelling
  • hypersensitivity
  • headache
  • paresthesia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, to maintain its effectiveness, it is best to store it at room temperature, specifically between 1°C and 30°C.

Appearance and packaging

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.